Skip to main content
SpringerLink
Log in

Hepatic venous pressure gradient: the facts

  • Conference paper
Portal Hypertension in the 21st Century

Abstract

Many of the clinical complications of cirrhosis are the direct consequences of the elevation of portal venous pressure (PVP). Portal hypertension is defined as a PVP of greater than the normal 5–10 mmHg. The degree of portal hypertension has been shown to correlate with the severity of liver disease, both functionally1 and histologically2, 3. However, direct portal venous measurement is invasive and cannot be routinely performed. As a surrogate, hepatic venous pressure gradient (HVPG) has been widely accepted as a measurement for PVP. The ease and safety of HVPG measurement has made it a valuable tool not only in the research arena, but also more and more in clinical practice.

Fact: An assertion, statement, or information containing or purporting to contain something having objective reality Webster’s Third New International Dictionary

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Braillon A, Cales P, Valla D, Gaudy D, Geoffroy P, Lebrec D. Inftuenece of the degree of liver failure on systemic and splanchnic hemodynamics and on response to propranolol in patients with cirrhosis. Gut. 1986:27:1204–9.

    Article  PubMed  CAS  Google Scholar 

  2. Krogsgaard K, Gluud C, Henriksen JH, Christoffersen P. Correlation between liver morphology and portal pressure in alcoholic liver disease. Hepatology. 1984:4:699–703.

    Article  PubMed  CAS  Google Scholar 

  3. Picchiotti R, Mingazzini PL, Scucchi L et al. Correlations between sinusoidal pressure and liver morphology in cirrhosis. J Hepatol. 1994:20:364–9.

    Article  PubMed  CAS  Google Scholar 

  4. Hallion L, Francois-Frank CA. Recherches experimentales executees a I’aide d’um novel appareil volumetrique sur I’innervation vaso-motrice de l’intestin. Arch Physiol Norm Pathol. 1896:8:493–508.

    Google Scholar 

  5. Thompson WP, Caughey JL, Whipple AO et al. Splenic vein pressure and congestive splenomegaly (Banty’s syndrome). J Clin Invest. 1937:16:571.

    Article  PubMed  CAS  Google Scholar 

  6. Myers JD, Taylor WJ. An estimation of PVP by occlusive catheterization of a hepatic venule. J Clin Invest. 1991:30:662–3.

    Google Scholar 

  7. Groszmann RJ, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004:39:280–2.

    Article  PubMed  Google Scholar 

  8. Groszmann RJ, Glickman MC, Blei AT, Storer E, Conn HO. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology. 1979:76:253–8.

    PubMed  CAS  Google Scholar 

  9. Bosch J, Mastai R, Kravetz D, Navasa M. Rodes J. Hemodynamic evaluation of patients with portal hypertension. Semin Liver Dis. 1986:6:309–17.

    Article  PubMed  CAS  Google Scholar 

  10. Seinlauf AF, García-Tsao G, Gupta T, Dickey K, Zakko MF, Groszmann RJ. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology. 1999:29:1070–3.

    Article  Google Scholar 

  11. Groszmann RJ, de Franchis R. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey W, editors. Schiff’s Diseases of the Liver. Philadelphia: Lippincott-Raven, 1999:387–442.

    Google Scholar 

  12. Boyer TD, Triger DR, Horisawa M, Redeker AG, Reynolds TB. Direct transhepatic measurement of portal vein pressure using a thin needle: comparison with wedged hepatic venous pressure. Gastroenterology. 1977:72:584–9.

    PubMed  CAS  Google Scholar 

  13. Groszmann RJ, Atterbury CE. Clinical applications of the measurement of portal venous pressure. J Clin Gastroenterol. 1980:2:379–86.

    Article  PubMed  CAS  Google Scholar 

  14. Pomier-Layrargues G, Kusielewicz D, Willems B et al. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology. 1985:5:415–18.

    Article  PubMed  CAS  Google Scholar 

  15. Perello A, Escorsell A, Bru C et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999:30:1393–7.

    Article  PubMed  CAS  Google Scholar 

  16. Deplano A, Migaleddu V, Pischedda A et al. Portohepatic gradient and portal hemodynamics in patients with cirrhosis due to hepatitis C virus infection. Dig Dis Sci. 1999:44:155–62.

    Article  PubMed  CAS  Google Scholar 

  17. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol. 2003:284:G567–74.

    PubMed  CAS  Google Scholar 

  18. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology. 1987:7:660–4.

    Article  PubMed  CAS  Google Scholar 

  19. Arroyo V, Bosch J, Gaya-Beltran J et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med. 1981:94: 198–201.

    PubMed  CAS  Google Scholar 

  20. Vinel JP, Cassigneul J, Louis A, Levade M, Pascal JP. Clinical and prognostic significance of portohepatic gradient in patients with cirhosis. Surg Gynecol Ohstet. 1982:155:347–52.

    CAS  Google Scholar 

  21. Vinel JP, Cassigneul J, Levade M, Voigt JJ, Pascal JP. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 1986:6:116–17.

    Article  PubMed  CAS  Google Scholar 

  22. Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 1988:8:222–7.

    Article  PubMed  CAS  Google Scholar 

  23. Tage-Jensen U, Henriksen JH, Christensen E, Widding A, Ring-Larsen H, Christensen NJ. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol. 1988:6:350–8.

    Article  PubMed  CAS  Google Scholar 

  24. Groszmann RJ, Bosch J, Grace N et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990:99:1401–7.

    PubMed  CAS  Google Scholar 

  25. Merkel C, Bolognesi M, Bellon S et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992:102:973–9.

    PubMed  CAS  Google Scholar 

  26. Vorobioff J, Groszmann RJ, Picabea E et al. Prognostic value of hepatic venous pressure measurement in alcoholic cirrhosis: A ten year prospective study. Gastroenterology. 1996:111:701–9.

    Article  PubMed  CAS  Google Scholar 

  27. Villanueva C, Aracil C, Lopez-Balaguer JM, Balanzo J. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rcbleeding. N Engl J Med. 1996:334:1624–9.

    Article  PubMed  CAS  Google Scholar 

  28. Patch D, Armonis A, Sabin C et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut. 1999:44:264–9.

    Article  PubMed  CAS  Google Scholar 

  29. Moitinho E, Escorsell A, Bandi JC et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999:117:626–31.

    Article  PubMed  CAS  Google Scholar 

  30. Abraldes JG, Tarantino I, Turnes J Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003:37:902–8.

    Article  PubMed  Google Scholar 

  31. Urbain D, Muls V, Makhoul E, Jeghers O, Thys O, Ham HR. Prognostic significance of hepatic venous pressure gradient in medically treated alcoholic cirrhosis: comparison to aminopyrine breath test. Am J Gastroenterol. 1993:88:856–9.

    PubMed  CAS  Google Scholar 

  32. Pomier-Layrargues G, Villeneuve JP, Willems B, Huet PM, Marleau D. Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo. Gastroenterology. 1987:93:1218–24.

    PubMed  CAS  Google Scholar 

  33. Groszmann, RJ, Garcia-Tsao G, Makuch R et al. Multicenter randomized placebo-controlled trial of non-selective beta-blockers in the prevention of the complications of portal hypertension: final results and identification of a predictive factor. Hepatology. 2003:38 (Suppl. 1):206A (abstract).

    Article  Google Scholar 

  34. García-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985:5:419–24.

    Article  PubMed  Google Scholar 

  35. Rigau J, Bosch J, Bordas JM et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989:96: 873–80.

    PubMed  CAS  Google Scholar 

  36. Viallet A, Marleau D, Huet M et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the porto hepatic gradient. Gastroenterology. 1975:69: 1297–300.

    PubMed  CAS  Google Scholar 

  37. Christensen U, Sorensen TI, Jensen LI, Aagaard J, Burcharth F. The free portal pressure in awake patients with and without cirrhosis of the liver. Liver. 1983:3:147–50.

    PubMed  CAS  Google Scholar 

  38. Viola C, Bosch J, Mastai R et al. Prognostic value of measurements of portal pressure in patients with cirrhosis. J Hepatol. 1987:5(Suppl. 1):S71 (abstract).

    Google Scholar 

  39. Vlavianos P, Gimson AES, Hayllar K et al. Prognostic significance of systemic and portal hemodynamic parameters in patients with cirrosis and previous variceal bleeding. Gut. 1990:31:A592 (abstract).

    Google Scholar 

  40. Lebrec D, De Fleury P, Rueff B, Nahum H, Benhamou JP. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980:79:1139–44.

    PubMed  CAS  Google Scholar 

  41. Adamson RJ, Butt K, Dennis CR et al. Prognostic significance of portal pressure in patients with bleeding esophageal varices. Surg Gynecol Obstet. 1977:145:353–6.

    Google Scholar 

  42. Ready JB, Robertson AD, Goff JS, Rector WG Jr. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991:100:1403–10.

    PubMed  CAS  Google Scholar 

  43. Westaby D, Polson RJ, Gimson AE, Hayes PC, Hayllar K, Williams R. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding. Hepatology. 1990:11:353–9.

    Article  PubMed  CAS  Google Scholar 

  44. Villanueva C, Ortiz J, Miñana J et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001:121:110–17.

    Article  PubMed  CAS  Google Scholar 

  45. Leevy CM, Zinke M, Baber J, Chey WY. Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis. Ann Intern Med. 1958:49:837–51.

    PubMed  CAS  Google Scholar 

  46. Reynolds TB, Geller HM, Kuzma OT, Redeker AG. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med. 1960;263:734–9.

    Article  PubMed  CAS  Google Scholar 

  47. D’Amico G, García-Tsao G, Calès P et al. Diagnosis of portal hypertension. How and when? In: de Franchis R, editor. Portal Hypertension. III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science, 2001:36–63.

    Google Scholar 

  48. Morali GA, Sniderman KW, Deitel KM et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol. 1992:16:249–50.

    Article  PubMed  CAS  Google Scholar 

  49. Rector WG Jr. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver. 1986:6:221–6.

    Article  PubMed  Google Scholar 

  50. Bosch J, Mastai R, Kravetz D, Navasa M, Rodes J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 1986:6:309 17.

    Article  PubMed  Google Scholar 

  51. Feu F, García-Pagán JC, Bosch J et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet. 1995:346:1056–9.

    Article  PubMed  CAS  Google Scholar 

  52. McCormick PA, Patch D, Greenslade L, Chin J, McIntyre N, Burroughs AK. Clinical vs hemodynamic response to drugs in portal hypertension. J Hepatol. 1998:28:1015–19.

    Article  PubMed  CAS  Google Scholar 

  53. Villanueva C, Minana J, Ortiz J et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001:345:647–55.

    Article  PubMed  CAS  Google Scholar 

  54. Merkel C, Bolognesi M, Sacerdoti D et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000:32:930–4.

    Article  PubMed  CAS  Google Scholar 

  55. Bureau C, Péron JM, Alric L et al. “A la carte” treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology. 2002:36:1361–6.

    PubMed  Google Scholar 

  56. Patch D, Sabin CA, Goulis J et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology. 2002:123:1013–19.

    Article  PubMed  CAS  Google Scholar 

  57. Groszmann RJ, Garcïa-Tsao G. Endoscopic variceal banding vs pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference? Gastroenterology. 2002:123:1388–91.

    Article  PubMed  Google Scholar 

  58. Burroughs AK, Groszmann RJ, Bosch J et al. Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure a better end point? Gut. 2002:50:425–7.

    Article  PubMed  CAS  Google Scholar 

  59. Friedman LS, Maddrey WC. Surgery in the patient with liver disease. Med Clin N Am. 1987:71:453–76.

    PubMed  CAS  Google Scholar 

  60. Bruix J, Castells A, Bosch J et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure. Gastroenterology. 1996: 111:1018–22.

    Article  PubMed  CAS  Google Scholar 

  61. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999:30:1434–40.

    Article  PubMed  CAS  Google Scholar 

  62. Lovet JM, Bruix J, Fuster J et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognosis power. Hepatology. 1998:27: 1572–7.

    Article  Google Scholar 

  63. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996:334:693–9.

    Article  PubMed  CAS  Google Scholar 

  64. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993: 218:145–51.

    Article  PubMed  CAS  Google Scholar 

  65. Groszmann RJ. The hepatic venous pressure gradient: has the time arrived for its application in clinical practice? Hepatology. 1996:24:739–41.

    Article  PubMed  CAS  Google Scholar 

  66. Thalheimer U, Mela M, Patch D, Burroughs AK. Monitoring target reduction in hepatic venous pressure gradient during pharmacological therapy of portal hypertension: a close look at the evidence. Gut. 2004:53:143–8.

    Article  PubMed  CAS  Google Scholar 

  67. Huet PM, Pomier-Layrargues G. The hepatic venous pressure gradient: “remixed and revisited”. Hepatology. 2004:39:295–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. VA Connecticut Healthcare System, Hepatic Hemodynamic Laboratory/111J, 950 Campbell Avenue, West Haven, CT, 06516, USA

    Roberto J. Groszmann

Authors
  1. Julio D. Vorobioff
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan G. Abraldes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto J. Groszmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Yale University School of Medicine, New Haven, CT, USA

    R. J. Groszmann

  2. Hepatic Hemodynamic Laboratory Liver Unit, Hospital Clinic, University of Barcelona, Spain

    J. Bosch

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media Dordrecht

About this paper

Cite this paper

Vorobioff, J.D., Abraldes, J.G., Groszmann, R.J. (2004). Hepatic venous pressure gradient: the facts. In: Groszmann, R.J., Bosch, J. (eds) Portal Hypertension in the 21st Century. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-1042-9_32

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-1042-9_32

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3774-7

  • Online ISBN: 978-94-007-1042-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation